$135 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 319 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SGEN | New | SEAGEN INC | $941,012,000 | – | 5,372,912 | +100.0% | 0.70% | – |
MS | New | MORGAN STANLEY | $827,361,000 | – | 12,072,976 | +100.0% | 0.62% | – |
GS | New | GOLDMAN SACHS GROUP INC | $191,203,000 | – | 725,050 | +100.0% | 0.14% | – |
DASH | New | DOORDASH INCcl a | $62,302,000 | – | 436,442 | +100.0% | 0.05% | – |
FCX | New | FREEPORT-MCMORAN INCcl b | $62,503,000 | – | 2,402,100 | +100.0% | 0.05% | – |
LUNG | New | PULMONX CORP | $50,557,000 | – | 732,500 | +100.0% | 0.04% | – |
ALLO | New | ALLOGENE THERAPEUTICS INC | $31,257,000 | – | 1,238,400 | +100.0% | 0.02% | – |
KEX | New | KIRBY CORP | $23,458,000 | – | 452,600 | +100.0% | 0.02% | – |
CVX | New | CHEVRON CORP NEW | $20,211,000 | – | 239,330 | +100.0% | 0.02% | – |
VLO | New | VALERO ENERGY CORP | $20,730,000 | – | 366,441 | +100.0% | 0.02% | – |
MASS | New | 908 DEVICES INC | $18,509,000 | – | 325,000 | +100.0% | 0.01% | – |
DOCU | New | DOCUSIGN INC | $8,970,000 | – | 40,350 | +100.0% | 0.01% | – |
WAT | New | WATERS CORP | $9,351,000 | – | 37,795 | +100.0% | 0.01% | – |
SKLZ | New | SKILLZ INC | $9,314,000 | – | 465,700 | +100.0% | 0.01% | – |
PEAK | New | HEALTHPEAK PROPERTIES INC | $5,169,000 | – | 171,000 | +100.0% | 0.00% | – |
SEER | New | SEER INC | $4,306,000 | – | 76,700 | +100.0% | 0.00% | – |
BYND | New | BEYOND MEAT INC | $2,725,000 | – | 21,800 | +100.0% | 0.00% | – |
SAFE | New | SAFEHOLD INC | $758,000 | – | 10,450 | +100.0% | 0.00% | – |
AVO | New | MISSION PRODUCE INC | $919,000 | – | 61,090 | +100.0% | 0.00% | – |
SIOX | New | SIO GENE THERAPIES INC | $146,000 | – | 52,625 | +100.0% | 0.00% | – |
TTWO | New | TAKE-TWO INTERACTIVE SOFTWAR | $353,000 | – | 1,700 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-08
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
BIOGEN INC. | 42 | Q3 2023 | 6.8% |
AMGEN INC. | 42 | Q3 2023 | 5.3% |
MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
FEDEX CORP | 42 | Q3 2023 | 3.3% |
SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
NN INC | November 09, 2022 | 1,763,640 | 4.0% |
AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.